Implementation of guideline‐directed medical therapy for heart failure

European Journal of Heart FailureEarly View Invited Editorial Implementation of guideline-directed medical therapy for heart failure Ulrich Laufs, Corresponding Author Ulrich Laufs [email protected] Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany Corresponding author. Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany. Tel: +49 341 9712650, Fax +49 341 9712659, Email: [email protected]Search for more papers by this authorRolf Wachter, Rolf Wachter Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, GermanySearch for more papers by this author Ulrich Laufs, Corresponding Author Ulrich Laufs [email protected] Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany Corresponding author. Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany. Tel: +49 341 9712650, Fax +49 341 9712659, Email: [email protected]Search for more papers by this authorRolf Wachter, Rolf Wachter Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, GermanySearch for more papers by this author First published: 19 June 2024 https://doi.org/10.1002/ejhf.3343 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.3267. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Savarese G, Lindberg F, Cannata A, Chioncel O, Stolfo D, Musella F, et al. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC. Eur J Heart Fail. https://doi.org/10.1002/ejhf.3295. Published online ahead of print 22/05/24. 10.1002/ejhf.3295 Web of Science®Google Scholar 2Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail 2021; 23: 352–380. https://doi.org/10.1002/ejhf.2115 10.1002/ejhf.2115 PubMedWeb of Science®Google Scholar 3Malgie J, Wilde MI, Clephas PRD, Emans ME, Koudstaal S, Schaap J, et al. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study. Eur J Heart Fail. https://doi.org/10.1002/ejhf.3267. Published online ahead of print 12/05/24. 10.1002/ejhf.3267 Web of Science®Google Scholar 4Clephas PRD, Malgie J, Schaap J, Koudstaal S, Emans M, Linssen GCM, et al. Guideline implementation, drug sequencing, and quality of care in heart failure: Design and rationale of TITRATE-HF. ESC Heart Fail 2024; 11: 550–559. https://doi.org/10.1002/ehf2.14604 10.1002/ehf2.14604 PubMedWeb of Science®Google Scholar 5Senni M, Wachter R, Witte KK, Straburzynska-Migaj E, Belohlavek J, Fonseca C, et al.; TRANSITION Investigators. Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: A subgroup analysis of the TRANSITION study. Eur J Heart Fail 2020; 22: 303–312. https://doi.org/10.1002/ejhf.1670 10.1002/ejhf.1670 CASPubMedWeb of Science®Google Scholar 6Abdin A, Schulz M, Riemer U, Haderi B, Wachter R, Laufs U, et al. Sacubitril/valsartan in heart failure: Efficacy and safety in and outside clinical trials. ESC Heart Fail 2022; 9: 3737–3750. https://doi.org/10.1002/ehf2.14097 10.1002/ehf2.14097 PubMedWeb of Science®Google Scholar 7Custodis F, Rohlehr F, Wachter A, Böhm M, Schulz M, Laufs U. Medication knowledge of patients hospitalized for heart failure at admission and after discharge. Patient Prefer Adherence 2016; 10: 2333–2339. https://doi.org/10.2147/PPA.S113912 10.2147/PPA.S113912 PubMedWeb of Science®Google Scholar 8Ewen S, Baumgarten T, Rettig-Ewen V, Mahfoud F, Griese-Mammen N, Schulz M, et al. Analyses of drugs stored at home by elderly patients with chronic heart failure. Clin Res Cardiol 2015; 104: 320–327. https://doi.org/10.1007/s00392-014-0783-2 10.1007/s00392-014-0783-2 PubMedWeb of Science®Google Scholar 9Laufs U, Griese-Mammen N, Krueger K, Wachter A, Anker SD, Koehler F, et al. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): Rationale and design of a randomized controlled trial, and results of the pilot study. Eur J Heart Fail 2018; 20: 1350–1359. https://doi.org/10.1002/ejhf.1213 10.1002/ejhf.1213 PubMedWeb of Science®Google Scholar 10Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, et al.; PHARM-CHF Investigators. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: Results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail 2019; 21: 1012–1021. https://doi.org/10.1002/ejhf.1503 10.1002/ejhf.1503 CASPubMedWeb of Science®Google Scholar 11Schumacher PM, Becker N, Tsuyuki RT, Griese-Mammen N, Koshman SL, McDonald MA, et al. The evidence for pharmacist care in outpatients with heart failure: A systematic review and meta-analysis. ESC Heart Fail 2021; 8: 3566–3576. https://doi.org/10.1002/ehf2.13508 10.1002/ehf2.13508 PubMedWeb of Science®Google Scholar 12Schulz M, Laufs U. Not obtaining a medication the first time it is prescribed: Primary non-adherence to cardiovascular pharmacotherapy. Clin Res Cardiol. https://doi.org/10.1007/s00392-023-02230-3. Published online ahead of print 20/05/23. 10.1007/s00392?023?02230?3 Web of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation